<?xml version="1.0" encoding="UTF-8"?>
<p>The case-fatality rate of 60% does not take into account potential mild or asymptomatic infections in people who are not seen by physicians or at hospitals. Serological studies in humans demonstrated that the incidence of H5N1 infection in exposed human populations is 1%â€“2% [
 <xref rid="JIS257C18" ref-type="bibr">18</xref>]. As a consequence, the case-fatality rate of A/H5N1 virus infection among humans may be significantly lower than the 60% deduced from laboratory-confirmed cases reported to the WHO.
</p>
